Reactions 1680, p81 - 2 Dec 2017 Carbamazepine/levetiracetam/ phenobarbital/CNP Unilateral congenital glaucoma: case report An infant described in International Registry of Antiepileptic Drugs and Pregnancy (EURAP) developed unilateral congenital glaucoma following in-utero exposure to carbamazepine, levetiracetam, phenobarbital and CNP [specific drug not stated; exact age, sex, dosage, route, time to reaction onset and outcome not stated]. The infant’s mother aged 28 years received vagus nerve stimulation (VNS) and carbamazepine, levetiracetam, phenobarbital and CNP for epilepsy. Eventually, an infant was born after gestational period of 36.6 weeks by normal delivery with a major malformation i.e. unilateral congenital glaucoma. Author comment: "One infant (3.9%; 95% CI 0.1%–19.6%) was born with a major malformation (unilateral congenital glaucoma), which is within the range expected among offspring of [antiepileptic drug]-treated women." Sabers A, et al. Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy. Epilepsy Research 137: 159-162, Nov 2017. Available from: URL: http://doi.org/10.1016/j.eplepsyres.2017.05.013 - Denmark 803284065 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera